A psychotic disorder is a mental health condition in which a person loses touch with reality, experiencing symptoms like hallucinations, delusions, or severely disorganized thinking. These disorders exist on a spectrum, from episodes lasting just days to chronic, lifelong conditions. What they share is a disruption in how the brain processes and interprets information, leading to experiences and beliefs that feel completely real to the person but don’t match what’s actually happening around them.
The Five Core Symptoms
Psychotic disorders are defined by five symptom domains. Not every person experiences all five, but a formal diagnosis typically requires at least two to be present for a meaningful stretch of time.
- Hallucinations: Sensing things that aren’t there. Hearing voices is the most common form, but hallucinations can also be visual, tactile, or involve smell and taste.
- Delusions: Fixed, false beliefs that persist despite clear evidence to the contrary. A person might believe they’re being surveilled, that they have special powers, or that outside forces are controlling their thoughts.
- Disorganized thinking: Speech that jumps between unrelated topics, falls apart mid-sentence, or becomes so scrambled that others can’t follow it. This reflects a breakdown in the brain’s ability to organize thoughts logically.
- Disorganized or abnormal motor behavior: This can range from unpredictable agitation to catatonia, a state where a person becomes physically unresponsive or holds rigid, unusual postures for long periods. Catatonia is now recognized as its own diagnosable condition when at least three of its twelve characteristic signs are present.
- Negative symptoms: These involve the absence of normal functioning. Emotional expression flattens, motivation drops, speech becomes sparse, and the ability to feel pleasure diminishes. Negative symptoms are often the most disabling over time because they erode a person’s capacity to work, maintain relationships, and care for themselves.
Types of Psychotic Disorders
The different psychotic disorders are largely distinguished by which symptoms dominate, how long they last, and whether mood episodes are also present.
Brief psychotic disorder involves a sudden onset of psychotic symptoms that resolve within a month. It’s often triggered by extreme stress or trauma and may never recur.
Schizophreniform disorder looks identical to schizophrenia but lasts between one and six months. Some people recover fully, while others progress to a schizophrenia diagnosis if symptoms persist beyond that six-month threshold.
Schizophrenia is the most well-known psychotic disorder and is chronic, meaning lifelong. It requires at least six months of continuous disturbance, including at least one month of active symptoms like hallucinations or delusions. A marked decline in the ability to work, relate to others, or manage daily self-care is part of the diagnostic picture.
Schizoaffective disorder combines the psychotic symptoms of schizophrenia with significant mood episodes, either depression or mania. The key distinction is that delusions or hallucinations must also occur during periods when the mood symptoms are absent, separating it from bipolar disorder or depression with psychotic features.
Delusional disorder is unusual in that it involves only one domain of psychosis: delusions. A person may hold a firmly fixed false belief for months or years while their thinking, behavior, and daily functioning remain otherwise intact. There are no hallucinations, no disorganized speech, and no negative symptoms.
What Happens in the Brain
For decades, psychosis was understood primarily as a problem with dopamine, the brain chemical involved in reward, motivation, and how we assign significance to experiences. An excess of dopamine signaling in certain brain pathways can make neutral events feel deeply meaningful, contributing to delusions and hallucinations. This is still the mechanism that most antipsychotic medications target.
More recent research points to glutamate, the brain’s primary excitatory chemical messenger, as an equally important player. The current model suggests that certain inhibitory brain cells don’t function properly, which leads to an excessive release of glutamate in areas like the prefrontal cortex and the memory-processing region of the brain. Brain imaging studies have confirmed elevated glutamate levels in these areas in people experiencing psychosis who haven’t yet started medication. This glutamate dysfunction also appears to disrupt dopamine activity, meaning the two systems are tightly linked rather than operating independently.
Risk Factors and Triggers
Genetics is the single largest contributor. Twin and family studies estimate the heritability of schizophrenia at 64 to 81 percent, and bipolar disorder (which can include psychotic features) at 60 to 85 percent. Having a close relative with a psychotic disorder substantially raises your risk, though it doesn’t guarantee you’ll develop one.
Environmental factors interact with that genetic vulnerability. Cannabis use has been repeatedly associated with increased psychosis risk across multiple studies and populations. Stimulant drugs like cocaine carry an independent association as well. Beyond substance use, the list of environmental risk factors includes complications during birth, childhood adversity and trauma, growing up in an urban environment, and migration. Even being born in winter or spring has been consistently linked to slightly elevated risk, possibly due to prenatal infection exposure.
Certain infections also play a role. The parasite Toxoplasma gondii, commonly acquired from undercooked meat or cat litter, is associated with an 80 percent increase in the odds of developing schizophrenia. Viral infections of the central nervous system during childhood roughly double the risk of adult schizophrenia, though bacterial infections of the same type do not show the same effect.
Early Warning Signs
Psychotic disorders rarely arrive without warning. Before full-blown symptoms appear, most people go through a prodromal phase where subtle changes in cognition, behavior, and functioning gradually emerge. Cognitive problems, including difficulty with memory, attention, and planning, are considered core features of this early phase and often show up before any hallucinations or delusions.
During the prodromal period, a person might start withdrawing socially, losing motivation, struggling at school or work, or expressing unusual or suspicious ideas that don’t quite reach the level of fixed delusions. Sleep patterns may shift. Emotional responses may seem blunted or inappropriate. These changes can be easy to dismiss as stress or depression, which is part of why early identification remains challenging. The prodromal phase can last months or even years before a first psychotic episode.
How Psychotic Disorders Are Treated
Antipsychotic medications are the primary treatment. These drugs work mainly by reducing dopamine activity in the brain pathways responsible for psychotic symptoms. There are two broad generations: older medications (developed in the 1950s and 1960s) and newer ones. A large analysis comparing 32 antipsychotic medications found that efficacy differences between them are mostly gradual rather than dramatic. The more meaningful differences show up in side effects. Older drugs tend to cause more movement-related problems like stiffness and tremors, while newer ones are more likely to cause metabolic effects like weight gain. The choice between them often comes down to which side effect profile is most acceptable for the individual.
Medication alone doesn’t address the full picture, particularly the cognitive difficulties and social withdrawal that erode quality of life. Cognitive behavioral therapy adapted for psychosis (CBTp) targets the way a person interprets and responds to their experiences. It helps people examine the beliefs surrounding their symptoms, build coping strategies, and stay active and socially connected. Randomized trials have shown that CBTp can reduce the severity of psychotic symptoms even in people who haven’t responded well to medication. In one notable study, while both CBTp and a basic social support intervention reduced symptoms initially, only the therapy group continued improving nine months later.
CBTp also works as a preventive tool, addressing factors like social isolation and inactivity that contribute to relapse. Behavioral activation, a component of the therapy, helps people rebuild routines and engage in meaningful activities, which supports long-term stability beyond what medication can achieve on its own.